Synergy Pharmaceuticals (SGYP) Stock Higher in After-Hours Trading Following Paulson Investment

NEW YORK (TheStreet) -- Synergy Pharmaceuticals (SGYP) shares continue to climb in after-hours trading today, up 1.03% to $3.93, following reports that John Paulson's Paulson & Co. hedge fund took a position in the gastrointestinal biopharmaceutical company.

Synergy Pharmaceuticals stock closed intraday trading up 10.51% to $3.89 on Monday after Paulson disclosed that it had purchased about 2.1 million shares of the company, a 2.1% stake valued at about $8.3 million.

The purchase makes Paulson the fifth largest shareholder of the New York City-based drug manufacturer.

SGYP Chart SGYP data by YCharts

If you liked this article you might like

The January Effect Is on Time This Year

The January Effect Is on Time This Year

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

4 Small-Caps on My Earnings Watch List

4 Small-Caps on My Earnings Watch List

Don't Panic About Biotech

Don't Panic About Biotech